ClexBio
Tissue engineering platform focused on developing lab-grown organs to eliminate the need for organ transplants.
1
Funding Rounds
$2.2m
Money raised
Overview
Tissue engineering platform focused on developing lab-grown organs to eliminate the need for organ transplants.
- Website:
- Business model: B2B
- Headquarters: Oslo
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company ClexBio has raised a total of $2.2m in funding over 1 rounds.
Key Insights:
- ClexBio Seed round, July 2021: $2.2m
ClexBio Seed round, July 2021
$2.2m
Industries
ClexBio is active in the following industries: